IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
70.48
-1.11 (-1.55%)
At close: Jan 21, 2026
BOM:524164 Revenue
IOL Chemicals and Pharmaceuticals had revenue of 5.68B INR in the quarter ending September 30, 2025, with 7.95% growth. This brings the company's revenue in the last twelve months to 21.70B, up 5.74% year-over-year. In the fiscal year ending March 31, 2025, IOL Chemicals and Pharmaceuticals had annual revenue of 20.79B, down -2.51%.
Revenue (ttm)
21.70B
Revenue Growth
+5.74%
P/S Ratio
0.97
Revenue / Employee
7.51M
Employees
2,891
Market Cap
21.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 20.79B | -535.80M | -2.51% |
| Mar 31, 2024 | 21.33B | -843.20M | -3.80% |
| Mar 31, 2023 | 22.17B | 330.90M | 1.52% |
| Mar 31, 2022 | 21.84B | 2.17B | 11.03% |
| Mar 31, 2021 | 19.67B | 725.10M | 3.83% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuland Laboratories | 15.33B |
| Shilpa Medicare | 13.43B |
| Bajaj HealthCare | 6.11B |
| Sudeep Pharma | 5.61B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Gujarat Themis Biosyn | 1.55B |
| Anlon Healthcare | 1.44B |
IOL Chemicals and Pharmaceuticals News
- 7 weeks ago - IOL Chemicals receives EDQM Certificate of Suitability for Minoxidil API - Business Upturn
- 2 months ago - Q2 2026 IOL Chemicals and Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - IOL Chemicals shares surge nearly 3.5% after Q1 profit rises 13% YoY - Business Upturn
- 6 months ago - IOL Chemicals Q1 results: Net profit rises 13% YoY to Rs 34 crore; EBITDA margin improves to 11.4% - Business Upturn
- 9 months ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn
- 9 months ago - Why are IOL Chemicals share price falling 3% today? Check here - Business Upturn
- 11 months ago - IOL Chemicals shares surge 4% after EDQM certification for Quetiapine Fumarate - Business Upturn
- 1 year ago - IOL Chemicals and Pharmaceuticals shares rise nearly 4% as board approves 1:5 stock split - Business Upturn